NL-OMON44966
Completed
Not Applicable
Mentalization-Based Treatment for Psychosis: a randomized controlled trial for outpatients with a nonaffective psychotic disorder. - MBT-P
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Non-affective psychotic disorders
- Sponsor
- Academisch Medisch Centrum
- Enrollment
- 90
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •\* At least six months of prior treatment, which should include relevant psycho\-education regarding nonaffective psychotic disorders (schizophrenia, schizophreniform or schizoaffective disorder (295\.x), delusional disorder (297\.1\), brief psychotic disorder (298\.8\) or psychotic disorder not otherwise specified (298\.9\))
- •\* Less than ten years of prior treatment for a nonaffective psychotic disorder.
- •\* Age 18\-55
- •\* Informed consent
Exclusion Criteria
- •\* Intellectual disabilities and/or illiteracy (having attended Dutch MLK or ZMLK education).
- •\* A lack of mastery of the Dutch language.
- •\* Severe addiction to such an extent that inpatient detoxification is necessary. After detoxification the patient is still eligible for participation in the study.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Mentalization Based Treatment for Psychosisonaffective psychotic disorders:schizophrenia, schizophreniform or schizoaffective disorder (295.x)delusional disorder (297.1)brief psychotic disorder (298.8)psychotic disorder not otherwise specified (298.9).NL-OMON21688Maastricht University, the Netherlands90
Not yet recruiting
Not Applicable
The effectiveness of Mentalization-Based Treatment-early (MBT-early) in adolescents with emerging borderline-personality disorder: a single case experimental desigBorderline personality disorder10034726NL-OMON55944De Viersprong6
Completed
Not Applicable
Mentalization-Based Treatment with and without Competitive Memory Training for patients with borderline personality disorder: randomnized controlled trialborderline10034726NL-OMON39537Stichting Rivierduinen
Completed
Phase 2
Methamphetamine associated psychosis and treatment with risperidone and halopridolMethamphetamine-associated psychosis.Mental and behavioural disorders due to use of other stimulants, including caffeineIRCT201507155280N19Vice chancellor for research of University of Social Welfare and Rehabilitation Sciences44
Completed
Not Applicable
Intensiv psychiatric-psychotherapeutic treatment for drug abusing patients during Opioid Substitution therapyF11.2F60.31F60.30F60.2F33.2F90.9Dissocial personality disorderRecurrent depressive disorder, current episode severe without psychotic symptomsHyperkinetic disorder, unspecifiedDRKS00015205Zentralinstitut für seelische Gesundheit Mannheim118